In addition, combinatorial treatment of SW872 and SW982 cells with AZ191 and doxorubicin resulted in increased cytotoxicity as detected by MTT assay, suggesting that Dyrk1B inhibition enhances the anti-cancer effects of doxorubicin [63]. This evidence concerns the gene DYRK1B and cancer.